Science
3 Things About CRISPR Therapeutics That Smart Investors Know – The Motley Fool
The company’s value isn’t reflected in typical performance metrics.
The gene-editing virtuoso CRISPR Therapeutics (NASDAQ:CRSP) is one of the most-watched stocks in biotech, and it’s no surprise why. CRISPR Therapeutics has a handful of different programs that could turn out to be low-risk cures for previously intractable…
Continue Reading
-
Noosa News20 hours agoTerrifying break-in at childcare centre on Sunshine Coast ends with death of man
-
General22 hours agoTrial of celebrity crocodile wrangler Matt Wright to hear from more witnesses
-
Noosa News21 hours agoWhy the Story Bridge won’t have a traffic lane repurposed for bikes and walkers
-
General23 hours agoPM kicks off roundtable with call for lasting reform